We Haven’t Scratched the Surface of Weight-Loss Drug Advances
Orforglipron is an oral drug from Eli Lilly that’s in trial stage. The New York Times reports that in a trial of over 500 patients, those “who took the highest dose lost an average of around 16 pounds after nine months.” The Times added that roughly “two-thirds of people who took the drug also saw their blood sugar […]
We Haven’t Scratched the Surface of Weight-Loss Drug Advances Read More »